Johnson & Johnson’s vaccine is being studied as a single- and two-dose adenovirus-based vaccine. It is an experimental viral vector vaccine that uses a weakened live pathogen (adenovirus) as the delivery method (vector) for transporting a recombinant vaccine for COVID-19.
https://www.verywellhealth.com/johnson-and-johnson-covid-19-vaccine-5093160